A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens

ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christa Litschko, Davide Oldrini, Insa Budde, Monika Berger, Jochen Meens, Rita Gerardy-Schahn, Francesco Berti, Mario Schubert, Timm Fiebig
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6c00b5c8ad3940f2af66b90fac7376c3
record_format dspace
spelling oai:doaj.org-article:6c00b5c8ad3940f2af66b90fac7376c32021-11-15T16:00:25ZA New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens10.1128/mBio.00641-182150-7511https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c32018-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00641-18https://doaj.org/toc/2150-7511ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferase activity to generate complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) polymers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall component of Gram-positive bacteria. Using modeling and multiple-sequence alignment, we showed homology between the predicted polymerase domains and WTA type I biosynthesis enzymes, creating a link between Gram-negative and Gram-positive cell wall biosynthesis processes. The polymerases of the new family are highly abundant and found in a variety of capsule-expressing pathogens such as Neisseria meningitidis, Actinobacillus pleuropneumoniae, Haemophilus influenzae, Bibersteinia trehalosi, and Escherichia coli with both human and animal hosts. Five representative candidates were purified, their activities were confirmed using nuclear magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by site-directed mutagenesis. IMPORTANCE Bacterial capsules play an important role in the interaction between a pathogen and the immune system of its host. During the last decade, capsule polymerases have become attractive tools for the production of capsule polymers applied as antigens in glycoconjugate vaccine formulations. Conventional production of glycoconjugate vaccines requires the cultivation of the pathogen and thus the highest biosafety standards, leading to tremendous costs. With regard to animal husbandry, where vaccines could avoid the extensive use of antibiotics, conventional production is not sufficiently cost-effective. In contrast, enzymatic synthesis of capsule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and works with high efficacy. The new capsule polymerase family described here vastly increases the toolbox of enzymes available for biotechnology purposes. Representatives are abundantly found in human pathogens but also in animal pathogens, paving the way for the exploitation of polymerases for the development of a new generation of vaccines for animal husbandry.Christa LitschkoDavide OldriniInsa BuddeMonika BergerJochen MeensRita Gerardy-SchahnFrancesco BertiMario SchubertTimm FiebigAmerican Society for MicrobiologyarticleTagFcapsular polysaccharidecapsuleenzymatic synthesisnuclear magnetic resonancepolymerasesMicrobiologyQR1-502ENmBio, Vol 9, Iss 3 (2018)
institution DOAJ
collection DOAJ
language EN
topic TagF
capsular polysaccharide
capsule
enzymatic synthesis
nuclear magnetic resonance
polymerases
Microbiology
QR1-502
spellingShingle TagF
capsular polysaccharide
capsule
enzymatic synthesis
nuclear magnetic resonance
polymerases
Microbiology
QR1-502
Christa Litschko
Davide Oldrini
Insa Budde
Monika Berger
Jochen Meens
Rita Gerardy-Schahn
Francesco Berti
Mario Schubert
Timm Fiebig
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
description ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferase activity to generate complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) polymers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall component of Gram-positive bacteria. Using modeling and multiple-sequence alignment, we showed homology between the predicted polymerase domains and WTA type I biosynthesis enzymes, creating a link between Gram-negative and Gram-positive cell wall biosynthesis processes. The polymerases of the new family are highly abundant and found in a variety of capsule-expressing pathogens such as Neisseria meningitidis, Actinobacillus pleuropneumoniae, Haemophilus influenzae, Bibersteinia trehalosi, and Escherichia coli with both human and animal hosts. Five representative candidates were purified, their activities were confirmed using nuclear magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by site-directed mutagenesis. IMPORTANCE Bacterial capsules play an important role in the interaction between a pathogen and the immune system of its host. During the last decade, capsule polymerases have become attractive tools for the production of capsule polymers applied as antigens in glycoconjugate vaccine formulations. Conventional production of glycoconjugate vaccines requires the cultivation of the pathogen and thus the highest biosafety standards, leading to tremendous costs. With regard to animal husbandry, where vaccines could avoid the extensive use of antibiotics, conventional production is not sufficiently cost-effective. In contrast, enzymatic synthesis of capsule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and works with high efficacy. The new capsule polymerase family described here vastly increases the toolbox of enzymes available for biotechnology purposes. Representatives are abundantly found in human pathogens but also in animal pathogens, paving the way for the exploitation of polymerases for the development of a new generation of vaccines for animal husbandry.
format article
author Christa Litschko
Davide Oldrini
Insa Budde
Monika Berger
Jochen Meens
Rita Gerardy-Schahn
Francesco Berti
Mario Schubert
Timm Fiebig
author_facet Christa Litschko
Davide Oldrini
Insa Budde
Monika Berger
Jochen Meens
Rita Gerardy-Schahn
Francesco Berti
Mario Schubert
Timm Fiebig
author_sort Christa Litschko
title A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
title_short A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
title_full A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
title_fullStr A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
title_full_unstemmed A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
title_sort new family of capsule polymerases generates teichoic acid-like capsule polymers in gram-negative pathogens
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c3
work_keys_str_mv AT christalitschko anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT davideoldrini anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT insabudde anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT monikaberger anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT jochenmeens anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT ritagerardyschahn anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT francescoberti anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT marioschubert anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT timmfiebig anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT christalitschko newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT davideoldrini newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT insabudde newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT monikaberger newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT jochenmeens newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT ritagerardyschahn newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT francescoberti newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT marioschubert newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
AT timmfiebig newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens
_version_ 1718426972486369280